Indeed, prostate cancer epithelial cell line PC3 and pancreatic cancer epithelial cell line SU86.86 showed increased vimentin expression and enhanced migration ability with CDKL2 ectopic expression (Fig. 2A). This evidence concerns the gene VIM and prostate cancer.